Pulmonary embolism: an underdiagnosed and underreported entity in Brazil-Reference-Cited by-同舟云学术

Pulmonary embolism: an underdiagnosed and underreported entity in Brazil

Published:2022-08-31 Issue: Volume: Page:e20220207
ISSN:1806-3756
Container-title:Jornal Brasileiro de Pneumologia
language:en
Short-container-title:J Bras Pneumol.

Author:

Henrique Miranda1 Carlos¹^ORCID

Affiliation:

1. 1. Divisão de Medicina de Emergência, Departamento de Clínica Médica, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto (SP), Brasil.

Publisher

Sociedade Brasileira de Pneumologia e Tisiologia

Reference10 articles.

1. 1. Gomes JA, Barros JEB, Nascimento ALOD, Rocha CAO, Almeida JPO, Santana GBA, et al. Hospitalizations for pulmonary embolism in Brazil (2008-2019): an ecological and time series study. J Bras Pneumol. 2022;48(3):e20210434. https://doi.org/10.36416/1806-3756/e20210434.

2. 2. Konstantinides SV, Barco S, Lankeit M, Meyer G. Management of Pulmonary Embolism: An Update. J Am Coll Cardiol. 2016;67(8):976-90. https://doi.org/10.1016/j.jacc.2015.11.061.

3. 3. Wiener RS, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med. 2011;171(9):831-7. https://doi.org/10.1001/archinternmed.2011.178.

4. 4. de Miguel-Díez J, Jiménez-García R, Jiménez D, Monreal M, Guijarro R, Otero R, et al. Trends in hospital admissions for pulmonary embolism in Spain from 2002 to 2011. Eur Respir J. 2014;44(4):942-50. https://doi.org/10.1183/09031936.00194213.

5. 5. Dentali F, Ageno W, Pomero F, Fenoglio L, Squizzato A, Bonzini M. Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy. Thromb Haemost. 2016;115(2):399-405. https://doi.org/10.1160/TH15-02-0172.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial intelligence-based pulmonary embolism classification: Development and validation using real-world data;PLOS ONE;2024-08-21

2. Foco na Embolia Pulmonar Aguda de Risco Intermediário. A Combinação de Biomarcadores é a Solução?;Arquivos Brasileiros de Cardiologia;2024